Further analysis of EGFR gene amplification copy data in NSCLC patients revealed significant differences in the probability of overall survival between NSCLC patients with different EGFR gene copy numbers, and the higher the increase in EGFR gene copy number, the worse the survival prognosis of the patients. Here, EGFR is linked to non-small cell lung carcinoma.